Randomised Cross-Over Study to Evaluate the Isolated Effect of Formoterol and Combined With Tiotropium on Breathlessness, Dynamic Hyperinflation and Exercise Tolerance in Moderate-to-Severe Stable COPD Patients
Phase of Trial: Phase IV
Latest Information Update: 22 Sep 2010
At a glance
- Drugs Tiotropium bromide (Primary) ; Formoterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 04 Dec 2009 Actual patient number (33) added as reported by ClinicalTrials.gov.
- 04 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.